rdf:type |
|
lifeskim:mentions |
umls-concept:C0003591,
umls-concept:C0007226,
umls-concept:C0023820,
umls-concept:C0026565,
umls-concept:C0035647,
umls-concept:C0086418,
umls-concept:C0205164,
umls-concept:C0333348,
umls-concept:C0441471,
umls-concept:C0449432,
umls-concept:C1179435,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1705248,
umls-concept:C2603343,
umls-concept:C2745888
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-10-25
|
pubmed:abstractText |
In contrast to lipoprotein components, few studies have analysed the importance of a combination of commonly available inflammatory markers as predictors of major cardiovascular events (MACE) in large healthy populations. We examined summary scores of inflammation and compared their predictive strength with that of lipoproteins in the Apolipoprotein MOrtality RISk (AMORIS) Study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1879-1484
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
213
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
299-305
|
pubmed:meshHeading |
pubmed-meshheading:20843515-Adult,
pubmed-meshheading:20843515-Aged,
pubmed-meshheading:20843515-Aged, 80 and over,
pubmed-meshheading:20843515-Apolipoprotein A-I,
pubmed-meshheading:20843515-Apolipoproteins,
pubmed-meshheading:20843515-Cohort Studies,
pubmed-meshheading:20843515-Female,
pubmed-meshheading:20843515-Heart Failure,
pubmed-meshheading:20843515-Humans,
pubmed-meshheading:20843515-Inflammation,
pubmed-meshheading:20843515-Ischemia,
pubmed-meshheading:20843515-Male,
pubmed-meshheading:20843515-Middle Aged,
pubmed-meshheading:20843515-Myocardial Infarction,
pubmed-meshheading:20843515-Risk,
pubmed-meshheading:20843515-Stroke
|
pubmed:year |
2010
|
pubmed:articleTitle |
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
|
pubmed:affiliation |
Department of Preventive Cardiology, Centre of Preventive Medicine, Oslo University Hospital, Ulleval, N-0407 Oslo, Norway. ingar.holme@uus.no
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|